276 related articles for article (PubMed ID: 22385042)
1. Histamine H4 receptor ligands and their potential therapeutic applications: an update.
Kiss R; Keserű GM
Expert Opin Ther Pat; 2012 Mar; 22(3):205-21. PubMed ID: 22385042
[TBL] [Abstract][Full Text] [Related]
2. Histamine H4 receptor ligands and their potential therapeutic applications.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
[TBL] [Abstract][Full Text] [Related]
3. Novel histamine H4 receptor ligands and their potential therapeutic applications: an update.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2014 Nov; 24(11):1185-97. PubMed ID: 25219452
[TBL] [Abstract][Full Text] [Related]
4. Major advances in the development of histamine H4 receptor ligands.
Smits RA; Leurs R; de Esch IJ
Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
[TBL] [Abstract][Full Text] [Related]
5. Histamine H3 and H4 receptors as novel drug targets.
Tiligada E; Zampeli E; Sander K; Stark H
Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin B1 receptor antagonists: a patent update 2009 - 2012.
Bozó É; Éles J; Keserű GM
Expert Opin Ther Pat; 2012 Dec; 22(12):1443-52. PubMed ID: 23033970
[TBL] [Abstract][Full Text] [Related]
7. A new generation of anti-histamines: Histamine H4 receptor antagonists on their way to the clinic.
Engelhardt H; Smits RA; Leurs R; Haaksma E; de Esch IJ
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):628-43. PubMed ID: 19736622
[TBL] [Abstract][Full Text] [Related]
8. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.
Savall BM; Edwards JP; Venable JD; Buzard DJ; Thurmond R; Hack M; McGovern P
Bioorg Med Chem Lett; 2010 Jun; 20(11):3367-71. PubMed ID: 20452213
[TBL] [Abstract][Full Text] [Related]
9. Azines as histamine H4 receptor antagonists.
Lazewska D; Kiec-Kononowicz K
Front Biosci (Schol Ed); 2012 Jan; 4(3):967-87. PubMed ID: 22202103
[TBL] [Abstract][Full Text] [Related]
10. The effect of pK(a) on pyrimidine/pyridine-derived histamine H4 ligands.
Savall BM; Meduna SP; Venable J; Wei J; Smith RC; Hack MD; Thurmond RL; McGovern P; Edwards JP
Bioorg Med Chem Lett; 2014 Dec; 24(23):5489-92. PubMed ID: 25455490
[TBL] [Abstract][Full Text] [Related]
11. Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators.
Tichenor MS; Thurmond RL; Venable JD; Savall BM
J Med Chem; 2015 Sep; 58(18):7119-27. PubMed ID: 25993395
[TBL] [Abstract][Full Text] [Related]
12. Piperazine modification in 2,4,6-triaminopyrimidine derivatives as histamine H4 receptor ligands.
Schreeb A; Walter M; Odadzic D; Schwed JS; Weizel L; Stark H
Pharmazie; 2013 Jul; 68(7):521-5. PubMed ID: 23923631
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
14. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines.
Thurmond RL; Gelfand EW; Dunford PJ
Nat Rev Drug Discov; 2008 Jan; 7(1):41-53. PubMed ID: 18172439
[TBL] [Abstract][Full Text] [Related]
15. Development of novel cellular model for affinity studies of histamine H(4) receptor ligands.
Karcz T; Kieć-Kononowicz K
Acta Biochim Pol; 2013; 60(4):823-7. PubMed ID: 24432340
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic treatment of vestibular deficits: therapeutic potential of histamine H4 receptors.
Wersinger E; Gaboyard-Niay S; Travo C; Soto E; Baez A; Vega R; Brugeaud A; Chabbert C
J Vestib Res; 2013; 23(3):153-9. PubMed ID: 24177347
[TBL] [Abstract][Full Text] [Related]
17. Clinical Development of Histamine H
Thurmond RL; Venable J; Savall B; La D; Snook S; Dunford PJ; Edwards JP
Handb Exp Pharmacol; 2017; 241():301-320. PubMed ID: 28233185
[TBL] [Abstract][Full Text] [Related]
18. The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study.
Ohsawa Y; Hirasawa N
Allergol Int; 2014 Dec; 63(4):533-42. PubMed ID: 25249063
[TBL] [Abstract][Full Text] [Related]
19. (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands.
Kamińska K; Ziemba J; Ner J; Schwed JS; Łażewska D; Więcek M; Karcz T; Olejarz A; Latacz G; Kuder K; Kottke T; Zygmunt M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
Eur J Med Chem; 2015 Oct; 103():238-51. PubMed ID: 26360048
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
Altenbach RJ; Adair RM; Bettencourt BM; Black LA; Fix-Stenzel SR; Gopalakrishnan SM; Hsieh GC; Liu H; Marsh KC; McPherson MJ; Milicic I; Miller TR; Vortherms TA; Warrior U; Wetter JM; Wishart N; Witte DG; Honore P; Esbenshade TA; Hancock AA; Brioni JD; Cowart MD
J Med Chem; 2008 Oct; 51(20):6571-80. PubMed ID: 18811133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
